questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Nucléoprotéines
Protéines chromosomiques nonhistones
Protéines de maintenance des minichromosomes
Protéines de maintenance des minichromosomes : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines de maintenance des minichromosomes : Questions médicales les plus fréquentes",
"headline": "Protéines de maintenance des minichromosomes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines de maintenance des minichromosomes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-06",
"dateModified": "2025-04-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines de maintenance des minichromosomes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines chromosomiques nonhistones",
"url": "https://questionsmedicales.fr/mesh/D002868",
"about": {
"@type": "MedicalCondition",
"name": "Protéines chromosomiques nonhistones",
"code": {
"@type": "MedicalCode",
"code": "D002868",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.664.235"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Composant-2 du complexe de maintenance des minichromosomes",
"alternateName": "Minichromosome Maintenance Complex Component 2",
"url": "https://questionsmedicales.fr/mesh/D064111",
"about": {
"@type": "MedicalCondition",
"name": "Composant-2 du complexe de maintenance des minichromosomes",
"code": {
"@type": "MedicalCode",
"code": "D064111",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.664.235.750.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Composant-3 du complexe de maintenance des minichromosomes",
"alternateName": "Minichromosome Maintenance Complex Component 3",
"url": "https://questionsmedicales.fr/mesh/D064126",
"about": {
"@type": "MedicalCondition",
"name": "Composant-3 du complexe de maintenance des minichromosomes",
"code": {
"@type": "MedicalCode",
"code": "D064126",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.664.235.750.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Composant-4 du complexe de maintenance des minichromosomes",
"alternateName": "Minichromosome Maintenance Complex Component 4",
"url": "https://questionsmedicales.fr/mesh/D064148",
"about": {
"@type": "MedicalCondition",
"name": "Composant-4 du complexe de maintenance des minichromosomes",
"code": {
"@type": "MedicalCode",
"code": "D064148",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.664.235.750.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Composant-5 du complexe de maintenance des minichromosomes",
"alternateName": "Minichromosome Maintenance Complex Component 5",
"url": "https://questionsmedicales.fr/mesh/D064150",
"about": {
"@type": "MedicalCondition",
"name": "Composant-5 du complexe de maintenance des minichromosomes",
"code": {
"@type": "MedicalCode",
"code": "D064150",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.664.235.750.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Composant-6 du complexe de maintenance des minichromosomes",
"alternateName": "Minichromosome Maintenance Complex Component 6",
"url": "https://questionsmedicales.fr/mesh/D064151",
"about": {
"@type": "MedicalCondition",
"name": "Composant-6 du complexe de maintenance des minichromosomes",
"code": {
"@type": "MedicalCode",
"code": "D064151",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.664.235.750.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Composant-7 du complexe de maintenance des minichromosomes",
"alternateName": "Minichromosome Maintenance Complex Component 7",
"url": "https://questionsmedicales.fr/mesh/D064168",
"about": {
"@type": "MedicalCondition",
"name": "Composant-7 du complexe de maintenance des minichromosomes",
"code": {
"@type": "MedicalCode",
"code": "D064168",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.664.235.750.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Composant-8 du complexe de maintenance des minichromosomes",
"alternateName": "Minichromosome Maintenance Complex Component 8",
"url": "https://questionsmedicales.fr/mesh/D064187",
"about": {
"@type": "MedicalCondition",
"name": "Composant-8 du complexe de maintenance des minichromosomes",
"code": {
"@type": "MedicalCode",
"code": "D064187",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.664.235.750.800"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Composant-9 du complexe de maintenance des minichromosomes",
"alternateName": "Minichromosome Maintenance Complex Component 9",
"url": "https://questionsmedicales.fr/mesh/D064188",
"about": {
"@type": "MedicalCondition",
"name": "Composant-9 du complexe de maintenance des minichromosomes",
"code": {
"@type": "MedicalCode",
"code": "D064188",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.664.235.750.900"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines de maintenance des minichromosomes",
"alternateName": "Minichromosome Maintenance Proteins",
"code": {
"@type": "MedicalCode",
"code": "D064110",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Qing Yang",
"url": "https://questionsmedicales.fr/author/Qing%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Department of Hepatic Surgery and Liver transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, 600# Tianhe Road, Guangzhou, 510630, China."
}
},
{
"@type": "Person",
"name": "Binhui Xie",
"url": "https://questionsmedicales.fr/author/Binhui%20Xie",
"affiliation": {
"@type": "Organization",
"name": "Department of Hepatobiliary Surgery, The First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China."
}
},
{
"@type": "Person",
"name": "Hui Tang",
"url": "https://questionsmedicales.fr/author/Hui%20Tang",
"affiliation": {
"@type": "Organization",
"name": "Department of Hepatic Surgery and Liver transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, 600# Tianhe Road, Guangzhou, 510630, China."
}
},
{
"@type": "Person",
"name": "Wei Meng",
"url": "https://questionsmedicales.fr/author/Wei%20Meng",
"affiliation": {
"@type": "Organization",
"name": "Department of Hepatic Surgery and Liver transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, 600# Tianhe Road, Guangzhou, 510630, China."
}
},
{
"@type": "Person",
"name": "Changchang Jia",
"url": "https://questionsmedicales.fr/author/Changchang%20Jia",
"affiliation": {
"@type": "Organization",
"name": "Cell-gene Therapy Translational Medicine Research Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Thawed plasma (TP) as a substitute for intravenous immune globulin (IVIG) to prevent hypogammaglobulinemia post-therapeutic plasma exchange.",
"datePublished": "2023-05-02",
"url": "https://questionsmedicales.fr/article/37147249",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.transci.2023.103716"
}
},
{
"@type": "ScholarlyArticle",
"name": "Membrane-based therapeutic plasma exchange: Proposed techniques for preventing filter failure.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37287385",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jca.22065"
}
},
{
"@type": "ScholarlyArticle",
"name": "Therapeutic plasma exchange in anti-N-methyl-D-aspartate receptor encephalitis.",
"datePublished": "2022-10-12",
"url": "https://questionsmedicales.fr/article/36165337",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1744-9987.13934"
}
},
{
"@type": "ScholarlyArticle",
"name": "Improved recurrence-free survival in patients with HCC with post-transplant plasma exchange.",
"datePublished": "2023-04-10",
"url": "https://questionsmedicales.fr/article/37029084",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/LVT.0000000000000147"
}
},
{
"@type": "ScholarlyArticle",
"name": "Therapeutic plasma exchange-free treatment for first-episode TTP: A systematic review.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/36878741",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.transci.2023.103661"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Nucléoprotéines",
"item": "https://questionsmedicales.fr/mesh/D009698"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines chromosomiques nonhistones",
"item": "https://questionsmedicales.fr/mesh/D002868"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines de maintenance des minichromosomes",
"item": "https://questionsmedicales.fr/mesh/D064110"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines de maintenance des minichromosomes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines de maintenance des minichromosomes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines de maintenance des minichromosomes",
"description": "Comment diagnostiquer une anomalie des protéines MCM ?\nQuels tests sont utilisés pour évaluer les MCM ?\nLes niveaux de MCM peuvent-ils être mesurés ?\nQuels marqueurs sont associés aux MCM ?\nLes MCM sont-elles liées à des cancers spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D064110?mesh_terms=Plasma+Exchange&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines de maintenance des minichromosomes",
"description": "Quels symptômes indiquent une dysfonction des MCM ?\nLes symptômes sont-ils spécifiques aux MCM ?\nComment les MCM affectent-elles la santé cellulaire ?\nLes MCM sont-elles liées à des symptômes neurologiques ?\nPeut-on observer des symptômes précoces de dysfonction MCM ?",
"url": "https://questionsmedicales.fr/mesh/D064110?mesh_terms=Plasma+Exchange&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines de maintenance des minichromosomes",
"description": "Peut-on prévenir les anomalies des MCM ?\nY a-t-il des tests de dépistage pour les MCM ?\nL'alimentation influence-t-elle les MCM ?\nLe stress affecte-t-il les MCM ?\nLes exercices physiques aident-ils les MCM ?",
"url": "https://questionsmedicales.fr/mesh/D064110?mesh_terms=Plasma+Exchange&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines de maintenance des minichromosomes",
"description": "Quels traitements ciblent les MCM ?\nLes thérapies géniques peuvent-elles aider ?\nY a-t-il des médicaments pour les MCM ?\nComment la chimiothérapie affecte-t-elle les MCM ?\nLes traitements sont-ils personnalisés pour les MCM ?",
"url": "https://questionsmedicales.fr/mesh/D064110?mesh_terms=Plasma+Exchange&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines de maintenance des minichromosomes",
"description": "Quelles complications peuvent survenir avec des anomalies MCM ?\nLes anomalies MCM sont-elles héréditaires ?\nComment les MCM affectent-elles le vieillissement ?\nLes MCM sont-elles liées à des maladies auto-immunes ?\nLes anomalies MCM peuvent-elles causer des troubles neurologiques ?",
"url": "https://questionsmedicales.fr/mesh/D064110?mesh_terms=Plasma+Exchange&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines de maintenance des minichromosomes",
"description": "Quels facteurs augmentent le risque d'anomalies MCM ?\nL'exposition à des toxines influence-t-elle les MCM ?\nLe tabagisme affecte-t-il les MCM ?\nLe vieillissement est-il un facteur de risque pour les MCM ?\nLes antécédents familiaux influencent-ils les MCM ?",
"url": "https://questionsmedicales.fr/mesh/D064110?mesh_terms=Plasma+Exchange&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des protéines MCM ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses de protéines peuvent identifier des anomalies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les MCM ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunobuvardage et la PCR sont couramment utilisés pour évaluer les MCM."
}
},
{
"@type": "Question",
"name": "Les niveaux de MCM peuvent-ils être mesurés ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux de MCM peuvent être mesurés par des techniques de biologie moléculaire."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont associés aux MCM ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs de prolifération cellulaire, comme Ki-67, sont souvent associés aux MCM."
}
},
{
"@type": "Question",
"name": "Les MCM sont-elles liées à des cancers spécifiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés de MCM sont souvent associés à divers types de cancers."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une dysfonction des MCM ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies dans la réplication de l'ADN peuvent entraîner des symptômes variés."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils spécifiques aux MCM ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes peuvent varier selon le type de maladie associée aux MCM."
}
},
{
"@type": "Question",
"name": "Comment les MCM affectent-elles la santé cellulaire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise fonction des MCM peut entraîner des erreurs dans la réplication de l'ADN."
}
},
{
"@type": "Question",
"name": "Les MCM sont-elles liées à des symptômes neurologiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre les MCM et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes précoces de dysfonction MCM ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des signes précoces peuvent inclure des anomalies de croissance cellulaire."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies des MCM ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène de vie et un suivi médical régulier peuvent aider à prévenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests de dépistage pour les MCM ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent être proposés pour les personnes à risque élevé."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle les MCM ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé cellulaire et la fonction des MCM."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il les MCM ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut perturber la fonction cellulaire, y compris celle des MCM."
}
},
{
"@type": "Question",
"name": "Les exercices physiques aident-ils les MCM ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la santé cellulaire et la fonction des MCM."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les MCM ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques de MCM sont en cours de développement pour le cancer."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques peuvent-elles aider ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique pourrait corriger les anomalies des MCM dans certains cas."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments pour les MCM ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments ciblant la voie de réplication de l'ADN sont en développement."
}
},
{
"@type": "Question",
"name": "Comment la chimiothérapie affecte-t-elle les MCM ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chimiothérapie peut perturber la fonction des MCM, affectant la réplication cellulaire."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés pour les MCM ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des profils de MCM des patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des anomalies MCM ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des cancers, des troubles de croissance et des maladies génétiques."
}
},
{
"@type": "Question",
"name": "Les anomalies MCM sont-elles héréditaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies peuvent être héréditaires, augmentant le risque de maladies."
}
},
{
"@type": "Question",
"name": "Comment les MCM affectent-elles le vieillissement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dysfonctionnements des MCM peuvent accélérer le vieillissement cellulaire et tissulaire."
}
},
{
"@type": "Question",
"name": "Les MCM sont-elles liées à des maladies auto-immunes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches suggèrent un lien potentiel entre les MCM et certaines maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les anomalies MCM peuvent-elles causer des troubles neurologiques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans les MCM peuvent être associées à des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'anomalies MCM ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs génétiques, environnementaux et liés au mode de vie peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines influence-t-elle les MCM ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines peut perturber la fonction des MCM."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il les MCM ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme est un facteur de risque connu pour des anomalies dans la fonction des MCM."
}
},
{
"@type": "Question",
"name": "Le vieillissement est-il un facteur de risque pour les MCM ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la fonction des MCM et augmenter le risque de maladies."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils les MCM ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies liées aux MCM peuvent augmenter le risque."
}
}
]
}
]
}
Intravenous immune globulin (IVIG) is a common treatment given after plasma exchange procedures to either prevent secondary hypogammaglobulinemia or as an adjunctive treatment for organ transplant rej...
Therapeutic plasma exchange (TPE) is commonly performed using membrane-based TPE (mTPE) and is prone to filter failure....
We report on 46 patients, with a total of 321 mTPE treatments using the NxStage machine. This was a retrospective study with an aim to evaluate the effect of heparin, pre-filter saline dilution and th...
We found that treatments that received both pre-filter heparin and saline had a statistically significant decrease in filter failure rate as compared to those that received neither (28.6% vs. 5.3%, P ...
Rate of filter failure in mTPE can be reduced by implementing several therapeutic interventions including pre-filter heparin and pre-filter saline solution. These interventions were not associated wit...
Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is the most commonly identified cause of autoimmune encephalitis. Therapeutic plasma exchange has been increasingly employed to treat this ...
Total plasma exchange (TPE) can play a role in cancer treatment by eliminating immune checkpoint inhibitors. This study investigated whether TPE improved oncological outcomes in patients with HCC who ...
Thrombotic thrombocytopenic purpura (TTP) is a thrombotic microangiopathy (TMA), and therapeutic plasma exchange (TPE) is currently the standard treatment. However, TPE sometimes cannot be implemented...
The PubMed, Embase, Web of Science and Cochrane Library databases were searched by two investigators independently to collect case reports and clinical studies on TTP patients treated without TPE. Aft...
A total of 5338 potentially relevant original studies were identified, from which 21 studies, including 14 cases, 3 case series and 4 retrospective studies, met eligibility requirements and were inclu...
Our study shows that TPE-free treatment may not increase the mortality of TTP patients, which provides a new treatment concept for patients with first episodes of TTP. However, the current evidence is...
Current knowledge related to employment of plasma exchange for treatment in COVID-19 is predominantly based on casuistic evidence in the form of single-center case-series. Published data encompass rep...
Dacomitinib-induced liver injury is often manifested by mild elevations of transaminases and bilirubin, and severe intrahepatic cholestasis caused by dacomitinib for simultaneous taking orally cytochr...
The patient was a 69-year-old woman with non-small cell lung cancer (NSCLC) who was prescribed oral dacomitinib for a month; she was given oral loratadine due to "allergic rhinitis" and metoprolol ext...
Intrahepatic cholestasis, drug-induced liver injury, and NSCLC....
After admission, the patient was prescribed adenosylmethionine, acetylcysteine, ursodeoxycholic acid capsule, methylprednisolone and fenofibrate for a month, with progressive elevation of liver bioche...
The patient was discharged after her liver parameters improved; the parameters remained normal at several follow-up visits, and she renewed the NSCLC regimens without dacomitinib after being evaluated...
Dacomitinib can induce severe intrahepatic cholestasis. It is considered that patients with intermediate metabolic CYP2D6 are susceptible to drug-induced liver injury caused by dacomitinib; plasma exc...
Therapeutic plasma exchange (TPE) is an extracorporeal process of separation of plasma from the cellular components of blood and its replacement with analogous fluids. This process is effective in tre...
To evaluate major indications of therapeutic plasma exchange in neurological disorders. To identify major complications associated and factors associated with premature cessation of the therapeutic pl...
A total of 508 TPE procedures were performed on 118 patients. In this study 61 patients were male and 57 patients were female. O-blood group was commonest blood group among the patients. GBS is the co...
TPE is a safe and effective treatment option for various immune-mediated neurological disorders and should be considered in managing these disorders....
We summarize evidence for the role of therapeutic plasma exchange (TPE) in the treatment of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV). TPE rapidly removes ANCA IgG, complem...
We analyze data from PEXIVAS and other trials of TPE in AAV, an up-to-date meta-analysis, and recently published large cohort studies....
There remains a role for the use of TPE in AAV in certain groups of patients, in particular those with severe renal involvement (Cr >500 μmol/L or dialysis-dependent). It should be considered in patie...
After the FDA gave emergency approval for the use of therapeutic plasma exchange in treatment for SARS-Coronoavirus-2, we analyzed its efficacy in patients who had failed all other known therapies....
This was a prospective observational study of 42 patients with SARS-Coronoavirus-2 who had failed conventional therapy and were treated with therapeutic plasma exchange. Pre- and postexchange clinical...
After therapeutic plasma exchange, there were significant improvements in some clinical parameters but mortality remained high; although better than the renal failure group (43.9% vs. 50.7%, p = 0.004...
SARS-CoV-2 patients who failed all other therapies had significant mortality with therapeutic plasma exchange; however, their survival was better than SARS-CoV-2 patients with stage 3 acute renal fail...